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Materials
KEY RESOURCES
Tamoxifen administration
Alternatively, tamoxifen (Sigma, T5648) was dissolved in corn oil (Sigma, C-8267) and injected subcutaneously at 20mg/ml concentration at postnatal stages P7 (30µl) in Ctrl and Chd7iKO animals. Brains were then collected at P20.
BrdU administration
5-Bromo-2'-deoxyuridine (BrdU, Sigma, 16880) was dissolved in NaCl at 10 mg/ml and injected intraperitoneally at 10 µl/g at postnatal stages P7 in tamoxifen-induced Ctrl and Chd7iKO animals, 1 hour before perfusion.
Demyelinating lesions
Before surgery, adult (2-3months) mice were weighted and anesthetized by intraperitoneal injection of mixture of ketamine (0.1 mg/g) and xylacine (0.01 mg/g).
Focal demyelinating lesions were induced by stereotaxic injection of 1μl of lysolecithin solution (LPC, Sigma, L4129, 1% in 0.9%NaCl) into the corpus callosum (CC; at coordinates: 1 mm lateral, 1.3 mm rostral to bregma, 1.7 mm deep to brain surface) using a glass-capillary connected to a 10μl Hamilton syringe. Animals were left to recover in a warm chamber before being returned into their housing cages. Brains were collected 2 or 4 days after lesions (2-4 dpi).
Tissue processing
Postnatal mice were anesthetized and perfused with 15 ml (for P7) and 25ml (for older animals) 2% paraformaldehyde (EMS, 15714). Brains were dissected, dehydrated in 20% sucrose at 4°C, embedded in OCT for freezing and cryosectioned at 14 μm.
Immunohistochemistry
Postnatal mouse brain cryosections (14-μm thick) were permeabilized and blocked in blocking buffer (0.05% Triton X-100 and 10% normal goat serum in PBS) for 1 hour and overlaid with primary antibodies overnight at 4°C. Antibody details are provided in supplemental material. After washing with 0.05% Triton X-100 in PBS, sections were incubated with secondary antibodies conjugated to Alexa488, Alexa594 or Alexa647
(Thermo, 1:1,000) and DAPI for 1 hour at room temperature, washed in PBS and mounted with Fluoromount-G (SouthernBiotech). For BrdU immunostaining, after normal staining for other required antibodies, sections were post-fixed with 4% PFA at RT for 5 minutes before pretreatment with 2N HCl in PBS at 37°C for 30min, and normal immunostaining protocol with anti-BrdU antibody.
For cells, coverslips were fixed in 4% paraformaldehyde for 10 minutes at room temperature and washed in PBS. They were blocked for 1h at room temperature in blocking buffer (0.05% Triton X-100 and 10% normal goat serum in PBS) and overlaid with primary antibodies for 30min at room temperature. After washing with 0.05%
Triton X-100 in PBS, cells were incubated with secondary antibodies conjugated to Alexa488, Alexa594 or Alexa647 (Thermo, 1:1,000) and DAPI for 30min at room temperature, washed in PBS and mounted with Fluoromount-G (SouthernBiotech).
Pictures of were taken with Zeiss microscope using Apotome system optical sectioning and deconvolution. Z-stack was used. Zen and ImageJ software packages were used to treat pictures and perform cell quantifications. For cells on coverslips, pictures were taken using CellInsight (Thermo Scientific).
MACSorted OPC culture
To control sorted cell population, cells were put on coverslips coated with poly-ornithine (Sigma, P4957) and cultured for a couple of hours in medium composed of DMEM high glucose GlutaMAX™ Supplement (ThermoFisher, 61965-026), B27 supplement (ThermoFisher, 17502048), EGF (Peprotech, AF-100-15, 20ng/ml), FGF (Peprotech, 100-18B, 10ng/ml) and PDGF (Peprotech, 100-13A, 10ng/ml) at 37°c. They were then fixed in 4% paraformaldehyde (PFA, diluted from 32% PFA, EMS, 15714) for 10 minutes, before processing to immunostaining.
In vitro lentiviral transduction
NSCs from WT, ROSA26R stop-floxed-YFP and Chd7 Flox/+ ; ROSA26R stop-floxed-YFP brains were dissociated and put in neurosphere medium enriched in EGF (20ng/ml; Peprotech; AF-100-15) and FGF (10ng/ml; Peprotech; 100-18B). Two days prior to transduction, cells were put in proliferation medium containing EGF, FGF and PDGF-AA (10ng/ml; Peprotech, 100-13A). Cells were then plated on coverslips coated with Poly-L-ornithine (Sigma, P4957) and transduced using lentiviral particles expressing the Cre recombinase and either a shRNA against Chd8 (GCAGTTACACTGACGTCTACA) or a scramble shRNA (TCGTCATAGCGTGCATAGGTTCAAGAGACCTATGCACGCTATGACGA). One day after transduction, cells were put in differentiation medium without growth factors and after 3 or 6 days of differentiation, fixed with 4% formaldehyde.
ChIP-Seq and data analysis
ChIP-seq assays were performed using iDeal ChIP-seq kit for Transcription Factors Representation of the data, overlapping, region annotation and correlations were done using Genomatix (www.genomatix.de) and IGV browser (https://software.broadinstitute.org/software/igv/). GO analysis were done using Pathway Studio (Elsevier, www.pathwaystudio.com/). "Promoters" correspond to regions 1000bp upstream of transcription start site (TSS) and 10bp downstream of TSS (Genomatix). "Enhancers" correspond to the regions commonly bound by Sox10 and Olig2 (4, 5) . Gene expression profiles have been analyzed from OL stage specific transcriptome and single-cell analysis (6, 7) .
RNA extraction and RT-qPCR.
RNAs were extracted from at least 10 5 MACsorted O4 + -cells from P7 Chd7iKO mice and their control littermates, using Nucleospin RNA kit (Macherey-Nagel, 740955). cDNAs were generated with SuperScript cDNA Synthesis Kit (Invitrogen, 18080051). RT-qPCR were performed using LightCycler® 96 real-time PCR system (Roche) and LightCycler® 480 SYBR Green I Master mix (Roche, 4707516001 ). Primers details are given in SI Appendix, Table S2 . β-actin was used for normalization.
RNA-seq and data analysis
RNA-seq libraries from control (n=7) and Chd7iKO (n=5) OPCs were prepared using TruSeq Stranded mRNA (Illumina 20020594) and sequenced with Illumina HiSeq 2500 platform. RNA-seq reads were aligned onto the mm10 reference transcriptome using bowtie and quantified using eXpress. The edgeR R-package was used to perform both data normalization and differential expression analyses. In all differential expression tests, genes were considered regulated when p-value < 0.05 and Fold change > 1.2.
Heatmap of gene expression was generated using R language (http://www.rproject.org). GO analysis of genes repressed and increased in Chd7iKO mutants was performed using Pathway Studio (Elsevier, www.pathwaystudio.com/).
ATAC-seq and data analysis
10 5 OPCs from control and Chd7iKO P7 mice were purified and lysate before ATAC-seq reaction, which was done as described before (8) . Libraries were done using Nextera DNA sample kit (Illumina, 15028212) and sequenced with Illumina HiSeq 2500 platform.
Reads from 5 controls and 5 Chd7iKO were uniquely mapped onto mm10 with bowtie2. Low-quality, mitochondria-and PCR-derived reads were all removed and peaks were called by using MACS. Regarding ChIP-seq data, only significant peaks>=100bp were considered for downstream analyses.
Statistical Analysis
Statistical parameters including the exact value of n, the definition of center, dispersion and precision measures (mean ± SEM) and statistical significance are reported in the Figures, Figure Legends and methods were used to predetermine sample sizes, but our sample sizes are similar to those generally employed in the field to balance experimental robustness with the 3R rule for animal experimentation. Quantifications were performed from at least three independent experiments. No randomization was used to collect all the data, but they were quantified blindly. Statistical analysis was performed in Prism software.
Data Resources
Raw data files have been deposited in the NCBI Gene Expression Omnibus under accession number GEO: GSE116601
Contact for Reagent and Resource Sharing
Further information and requests for reagents may be directed to, and will be fulfilled by the corresponding author Carlos Parras (carlos.parras@upmc.fr). Note that the lesion core devoid of OLs has been excluded from the representation. Ctx, cortex;
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Stri, striatum; CC, corpus callosum. Scale bar, 20µm.
F -Barplot representing the gene ontology (GO) analysis of the Chd7/Chd8-or Chd8-only bound genes.
G -Venn diagram depicting the overlap between ASD risk-genes and regulated genes in
Chd7iKO OPCs. J -Immunostaining of Nkx2.2, β-Tubulin and PDGFRα in WT cells after 6 days in differentiation medium. Scale bar: 10 μm. *P < 0.05, **P < 0.01 and ***P < 0.001. 
Nkx2.2, Gpr17
• Chd7 promotes OPC survival by chromatin-closing and transcription repression of p53 Table S1 . List of oligodendroglia stage-specific genes used for quantificating the binding of key transcription factors (Sox10, Olig2, Ascl1) and chromatin remodelers (Chd7, Chd8 and Brg1) to promoter and enhancer regions of each gene group (OPC, iOL and mOL) in OPCs and OLs. Table S2 . List of mouse primers used for RTqPCR.
